In this review, we first discuss the molecular mechanisms by which IL-1B drives the metastatic cascade of breast cancer bone metastasis before exploring potential methods for targeting IL-1 signalling that may benefit patients in the future. This evidence concerns the gene IL1A and breast cancer.